NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,237.20 +35.93 (+0.21%) CRUDE OIL
82.93 +0.12 (+0.14%) GOLD FUTURES
2,331.20 -7.20 (-0.31%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,475.16 -1,922.61 (-3.60%)
iBio, Inc. (IBIO)
After hours:
| Previous close | 1.9000 |
| Open | 1.9800 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 800 |
| Day's range | 1.8302 - 1.9800 |
| 52-week range | 1.0200 - 22.8000 |
| Volume | |
| Avg. volume | 3,892,725 |
| Market cap | 16.362M |
| Beta (5Y monthly) | -3.52 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -15.2500 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireiBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative AI/Machine Learning platform to discover, engineer and develop obesity-focused therapeutic targets – – Concurrent $15M PIPE financing, announced yesterday, extends cash runway through fiscal year 2025 and provides support for collaboration – – Company to host webcasted conference call today at 8:30 a.m. EDT to discuss AstralBio collaboration – B
- GlobeNewswire
iBio Announces $15.0 Million Private Placement
– Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announces today that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds to the Company of approximately $15.0 million, before deducting placement
Insider Monkey12 Best Biotech Penny Stocks to Invest In
In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Penny Stocks to Invest In. The past few years have been a topsy-turvy ride for the biotech sector. There was a massive increase in […]
